Vise Technologies, Inc. Bio N Tech Se Transaction History

Vise Technologies, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$98.5 - $125.08 $199,167 - $252,911	2,022 New	2,022 $219,000
Q1 2023 May 10, 2023	SELL	$122.57 - $153.67 $52,459 - $65,770	-428 Reduced 18.07%	1,940 $241,000
Q4 2022 Feb 09, 2023	BUY	$118.43 - $186.05 $15,632 - $24,558	132 Added 5.9%	2,368 $355,000
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $285,425 - $409,433	2,236 New	2,236 $302,000

365

39.6M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

Stay updated on Vise Technologies, Inc. with notifications on news.